Life Sciences

Holliston biotechnology company Biostage Inc. cut its yearly losses by $3.4 million through reductions in research & development and administrative expenses.

Framingham life science consulting firm Alira Health announced Tuesday it has closed $35 million in equity financing.

Arranta Bio, a microbiome contract development and manufacturing organization, is planning a $150-million facility in Boxborough to drastically increase its capacity beyond its sites in Watertown and Florida.

The Worcester life sciences incubator Massachusetts Biomedical Initiatives has won a $252,000 federal grant to help spur regional economic development and biomedical entrepreneurship.

Southborough life sciences firm Veristat announced on Thursday that WindRose Health Investors now holds majority ownership of the company.

Life sciences analytics technology firm SCIEX has announced the appointment of Joe Fox as the Framingham-based company's new president.

Marlborough early stage drugmaker Phio Pharmaceuticals, has ended the year in a strong position, with enough funding to continue its current programs for the next two years, the company announced last week.

While millions of Americans have learned to work from home, developing COVID-19 vaccines requires office and lab space.

Marlborough medical device company Boston Scientific has released newly obtained study data speaking to the effectiveness of its TheraSphere Y-90 Glass Microspheres cancer treatment.

Cytovia Therapeutics, a biopharmaceutical manufacturer of cancer-fighting cell therapies, has expanded its research and development operations with a new lab in Natick opened this month.